Results 171 to 180 of about 8,416 (212)

Prevalence of Plasmodium falciparum parasites harbouring chloroquine-resistant but not artemisinin-resistant alleles in Busia County, Western Kenya. [PDF]

Malar J
Onchieku NM, Gesusu N, Caspar E, Karani L, Thiong'o K, Kamau L, Kiboi D, Thiebaut L, Ma L, Kimani F, Matoke-Muhia D, Ménard D.   +11 more
europepmc   +1 more source

Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ? [PDF]

Malar J
White NJ, Mehra S, Watson JA.
europepmc   +1 more source

Assessment of ex vivo antimalarial drug efficacy in African Plasmodium falciparum parasite isolates, 2016-2023: a genotype-phenotype association study. [PDF]

EBioMedicine
Rosado J, Fola AA, Cojean S, Sarrasin V, Coppée R, Bailly J, Zaffaroulah R, Bouzayene A, Cicéron L, Houzé L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houzé S, Investigation Study Group.   +17 more
europepmc   +1 more source

Modified dosing schedule efficacy of fosmidomycin and clindamycin against murine malaria Plasmodium berghei. [PDF]

Int J Parasitol Drugs Drug Resist
Walker LA, Bagonza V, Bobb B, Sullivan DJ.   +3 more
europepmc   +1 more source

The usual suspect-malaria? Diagnostic challenges in post-artesunate delayed haemolysis: a clinical laboratory perspective through a case report. [PDF]

Malar J
Molnar E, Cabral PM, Portal F, Guimarães AR, Santos L, Guimarães JT.   +5 more
europepmc   +1 more source

A just war on bugs? Ethical differences between antimalarial resistance and antibacterial resistance. [PDF]

BMJ Glob Health
Johnson T, von Seidlein L, Cheah PY.
europepmc   +1 more source

Mapping Antimalarial Drug Resistance in Mozambique: A Systematic Review of <i>Plasmodium falciparum</i> Genetic Markers Post-ACT Implementation. [PDF]

Int J Mol Sci
Chaves CRS, da Silva C, Salamandane A, Nogueira F.   +3 more
europepmc   +1 more source

Spatio-temporal trends of artemisinin-based combination therapy efficacy from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Bohissou FET, Nassa GJW, Sondo P, Rouamba T, Inoue J, Kaboré B, Asua V, Held J, Tinto H.   +8 more
europepmc   +1 more source

Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda: a promising approach for managing therapies in malaria-endemic countries. [PDF]

BMJ Glob Health
Muvunyi CM, Gashema P, Mbituyumuremyi A, Iradukunda PG, Siddig EE, Niyonzima JD, Hakizimana E, Umulisa N, Noor AM, Mugabo Semahore J, Tuyishime A, Harelimana JD, Umuhire J, Butera Y, Nsanzimana S.   +14 more
europepmc   +1 more source

Global assessment of partial artemisinin resistance: multicenter trial across Kenya, Peru, and Thailand in patients with uncomplicated Plasmodium falciparum malaria. [PDF]

Int J Infect Dis
Andagalu B, Smith E, Durand S, Valdivia HO, Onyango I, Spring M, Pattaraporn V, Baldeviano GC, Majid E, Sriwichai S, Cummings J, Tapia L, Akala H, Gosi P, Cabezas C, Juma D, Wongararunkochakorn S, Sihuincha M, Chaisatit C, Chebon-Bore L, Kuntawunginn W, Halbach A, Kodchakorn C, Thamnurak C, Praditpol C, Saingam P, Edgel KA, Saunders D, Cheruiyot A, Chuang I, Milgotina E, Fernandes P, Lescano AG, Boonyalai N, Kamau E, Forshey BM, Cinkovich S, Bethell D, Jongsakul K, Fukuda M.   +39 more
europepmc   +1 more source